No influence of pantoprazole on the pharmacokinetics of phenytoin
- PMID: 8793606
No influence of pantoprazole on the pharmacokinetics of phenytoin
Abstract
Twenty-three healthy, male volunteers completed this doubleblind, randomized, placebo controlled, 2-period crossover study to assess the influence of multiple doses of pantoprazole on single-dose phenytoin pharmacokinetics. During each treatment period, the volunteers received either one 40 mg pantoprazole tablet or placebo for 7 days. In addition, a single-dose of 300 mg (3 x 100 mg capsules) phenytoin sodium was administered on day 4 of each treatment period. A 14-day wash-out period was allowed between phenytoin administrations. The results indicate that pantoprazole neither affects the rate nor the extent of absorption, nor the elimination of phenytoin.
Similar articles
-
Pantoprazole does not interact with the pharmacokinetics of carbamazepine.Int J Clin Pharmacol Ther. 1998 Oct;36(10):521-4. Int J Clin Pharmacol Ther. 1998. PMID: 9799054 Clinical Trial.
-
No influence of pantoprazole on the pharmacokinetics of phenytoin.Int J Clin Pharmacol Ther. 1995 May;33(5):304-7. Int J Clin Pharmacol Ther. 1995. PMID: 7655771 Clinical Trial.
-
Lack of pharmacokinetic interaction between pantoprazole and diclofenac.Int J Clin Pharmacol Ther. 1996 May;34(1 Suppl):S76-80. Int J Clin Pharmacol Ther. 1996. PMID: 8793607 Clinical Trial.
-
Lack of pantoprazole drug interactions in man.Int J Clin Pharmacol Ther. 1994 Aug;32(8):385-99. Int J Clin Pharmacol Ther. 1994. PMID: 7981922 Review.
-
Pharmacokinetics of pantoprazole in man.Int J Clin Pharmacol Ther. 1996 May;34(1 Suppl):S7-16. Int J Clin Pharmacol Ther. 1996. PMID: 8793599 Review.
Cited by
-
Omeprazole induces gastric permeability to digoxin.Dig Dis Sci. 2010 May;55(5):1255-63. doi: 10.1007/s10620-009-0851-z. Epub 2009 Jun 10. Dig Dis Sci. 2010. PMID: 19513837
-
Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.Clin Pharmacokinet. 2000 Oct;39(4):295-309. doi: 10.2165/00003088-200039040-00005. Clin Pharmacokinet. 2000. PMID: 11069215 Review.
-
Safety of potent gastric acid inhibition.Drugs. 2005;65 Suppl 1:97-104. doi: 10.2165/00003495-200565001-00013. Drugs. 2005. PMID: 16335863 Review.
-
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006. Drugs. 2003. PMID: 12487624 Review.